Background-HCN channels activate the pacemaker current I f , which is thought to contribute significantly to generation and regulation of heart rhythm. HCN4 represents the dominant isotype in the sinoatrial node and binding of cAMP was suggested to be necessary for autonomic heart rate regulation. Methods and Results-In a candidate gene approach, a heterozygous insertion of 13 nucleotides in exon 6 of the HCN4 gene leading to a truncated cyclic nucleotide-binding domain was identified in a 45-year-old woman with sinus bradycardia. Biophysical properties determined by whole-cell patch-clamp recording of HEK293 cells demonstrated that mutant subunits (HCN4-695X) were insensitive to cAMP. Heteromeric channels composed of wild-type and mutant subunits failed to respond to cAMP-like homomeric mutant channels, indicating a dominant-negative suppression of cAMP-induced channel activation by mutant subunits. Pedigree analysis identified 7 additional living carriers showing similar clinical phenotypes, that is, sinus node dysfunction with mean resting heart rate of 45.9Ϯ4.6 bpm (nϭ8) compared with 66.5Ϯ9.1 bpm of unaffected relatives (nϭ6; PϽ0.01). Clinical evaluation revealed no ischemic or structural heart disease in any family member. Importantly, mutant carriers exhibited normal heart rate variance and full ability to accelerate heart rate under physical activity or pharmacological stimulation. Moreover, mutant carriers displayed distinctive sinus arrhythmias and premature beats linked to adrenergic stress. Conclusions-In humans, cAMP responsiveness of I f determines basal heart rate but is not critical for maximum heart rate, heart rate variability, or chronotropic competence. Furthermore, cAMP-activated I f may stabilize heart rhythm during chronotropic response. (Circ Arrhythm Electrophysiol. 2010;3:542-552.)
T he sick sinus syndrome accounts for about half of all cases necessitating pacemaker implantation. 1 Primary sinus node dysfunction importantly contributes to the syndrome and has been related to inherited forms. 2 According to current knowledge, I f is considered the most important link to automaticity by determining the slope of diastolic depolarization of sinoatrial nodal cells and is assumed to be the key factor in generation and modulation of heart rhythm. [3] [4] [5] The mammalian genome encodes 4 HCN channels (HCN1-4) that activate I f in response to hyperpolarization. 6 Comparative analysis of HCN transcription revealed remarkable differences in their distribution, believed to underlie significant aspects in generation of I f current. 7, 8 HCN4 is the dominant HCN isotype in the human adult sinoatrial node (SAN), 8 and HCN4 mutations are associated with inherited sinus node bradycardia. 9 -12 HCN channels are directly regulated by cAMP, which binds to the cyclic nucleotide-binding domain (CNBD) and elicits a positive shift in the voltage dependence of activation, with HCN4 channels showing the highest cAMP sensitivity. 13, 14 Recently, a patient was reported expressing a truncated HCN4 protein insensitive to changes of intracellular cAMP. 9 Clinical features included marked sinus bradycardia and chronotropic incompetence and strongly Clinical Perspective on p 552 encouraged the idea that cAMP-mediated modulation of I f is the dominant mechanism for heart rate regulation. 9 This view, however, was challenged by Cre-mediated ablation of HCN4 gene activity in adult mouse hearts 15 and by generation of mice expressing HCN4 channels insensitive to cAMP. 16 Adult mice lacking most of I f activity showed no bradycardia but developed recurrent sinus pauses. Of note, in both mouse models, 15, 16 acceleration of heart rate appeared normal during sympathetic stimulation. Thus, the precise contribution of HCN4 to sinus node function still is unresolved, and in particular the role of HCN4 in human autonomic heart rate response has yet to be established. 17, 18 In the present study, we examined 14 members of a German family with 8 members carrying a novel HCN4 mutation (HCN4-695X) associated with sinus bradycardia. An insertion of 13 nucleotides in exon 6 of the HCN4 gene generates a frame shift leading to a truncated CNBD. Biophysical properties of mutant channels expressed in HEK293 cells revealed a complete loss of I f modulation by cAMP. Heteromeric channels composed of wild-type and mutant subunits failed to respond to cAMP-like homomeric mutant channels, indicating a dominant-negative suppression of cAMP responsiveness of the I f current by mutant HCN4-695X subunits. Patients expressing mutant subunits insensitive to cAMP showed sinus bradycardia and exercise-induced arrhythmias but displayed regular chronotropic competence under both physical activity and pharmacological stimulation.
Methods

Patients and Clinical Investigations
Our study is based on a 4-generation family of German origin comprising 16 family members, of which 14 have been examined ( Figure 1A through 1C ). Evaluation included clinical examination, 12-lead ECG, echocardiography, 24-hour Holter recording (13 patients) and treadmill-test (13 patients) . Holter recordings were analyzed by computer system (H-Scribe 4.0, Mortara) and confirmed by electrophysiological validation. Heart rate variability was measured (10 patients) by Kleiger standard deviation 19 of the N-N intervals (normal Ͼ100 ms, low Ͻ50 ms). For Poincaré plots, N-N intervals obtained during 24-hour Holter recording were used. Current N-N interval (x-axis) was plotted against the subsequent N-N ϩ1 interval (y-axis). 20 Separate plots for daytime (14-hour recording) and nighttime (10-hour recording) were illustrated. Basal heart rates were evaluated by 12-lead ECG with patients at rest 10 minutes before and during measurement. In this way, shortcomings of average heart rates (Holter recording) caused by differences in physical exertion among individuals could be prevented. Four patients were further examined by dobutamine stress-MRI (increasing doses of dobutamine 10/20/30/40 g/kg body weight every 3 minutes plus 0.25 mg atropine at the conclusion of the dobutamine challenge).
All patients gave written informed consent for clinical and genetic investigations according to the research protocol, which had been approved by the local ethics committee. The investigation conforms with the principles outlined in the Declaration of Helsinki.
Mutation Analysis
HCN4 exons were amplified from genomic DNA according to Schulze-Bahr et al. 9 The PCR mix contained 25 ng template DNA, 25 pM of each primer, 200 mol/L 4-dNTP, 0.7 U of HotStarTaq 
Cloning and Mutagenesis of HCN4
Human HCN4 cDNA was amplified from human left ventricular mRNA (Biocat) and cloned into cytomegalovirus promotor directed expression vectors. The mutation was introduced by site-directed mutagenesis (QuikChange II Site-Directed Mutagenesis Kit, Stratagene), and wild-type and mutant sequences were verified using an ABI Bio Systems 377 Prism Automated DNA Sequencer (Applied Biosystems).
Cell Culture
Human embryonic kidney (HEK293) cells were cultured in DMEM with 2 mmol/L glutamine, 10% FCS, 100 U/mL penicillin-G sodium, and 100 g/mL streptomycin sulfate in 5% CO 2 at 37°C. HEK293 cells grown on glass cover slips (CS) of 12-mm diameter (Assistent Glaswarenfabrik, Hecht KG) were transfected with 0.6 g plasmid DNA/CS. In coexpression experiments, equal amounts (0.3 g) of wild-type and mutant plasmid DNA were transfected. Successfully transfected cells were visualized either by coexpressed DsRed protein or CD8 antigen 22 (0.1 g DNA/CS) identified by anti-CD8 antibody coated Dynabeads (Invitrogen).
Electrophysiological Recordings
Membrane currents were recorded 1 to 2 days after transfection under voltage-clamp conditions using conventional whole-cell patch-clamp techniques at room temperature (21°C to 23°C) with an Axopatch 200B amplifier (Axon Instruments). Signals were analogfiltered with a low-pass Bessel filter (1-kHz corner frequency). Series resistance was compensated by 70% to 80%. Data were digitized (CED1401 micro MKII; CED), analyzed, and stored on a PC using Signal3 software (CED). Voltage commands were applied through the CED board as described below. Pipettes were pulled from borosilicate glass (inner diameter, 0.86 mm; outer diameter, 1.5 mm) with a Flaming/Brown Puller P-97 (Sutter Instruments). The patch pipettes contained (in mmol/L): KCl 130, NaCl 10, MgCl 2 0.5, EGTA 1, HEPES 5, MgATP 2, NaGTP 0.1, and Phosphocreatine 5, pH 7.4 (KOH). The bath solution contained (in mmol/L): KCl 30, NaCl 110, CaCl 2 1.8, MgCl 2 0.5, and HEPES 5; pH 7.4 (NaOH). Intracellular and extracellular solution osmolarity was adjusted with glucose to 290 and 300 mOsmol/L, respectively.
To evaluate functional properties of HCN4 channels, different voltage protocols were used. For activation characteristics, voltage steps ranging from Ϫ50 to Ϫ140 mV (holding potential: Ϫ40 mV; increment: 10 mV; interval: 30 seconds) were applied. To prevent influence of strong negative potentials on membrane stability and recording conditions, the duration of negative voltage steps was reduced with increasing hyperpolarization from 24 seconds (Ϫ50 mV) to 3 seconds (Ϫ140 mV). Each voltage step was followed by a final command step to Ϫ140 mV, which established an identical driving force for each sweep. The fast current component was used as a direct measure of the steady-state conductance at the preceding command potential. Deactivation properties were assessed using a double pulse protocol. 23 From a holding potential of Ϫ40 mV, 2 successive pulses to Ϫ120 mV were applied, separated by increasing time intervals in the range of 1 to 7 seconds (increment, 1 second). The reversal potential (E rev ) was determined by activating hyperpolarizing pulses (Ϫ120 mV; 3 seconds), subsequently followed by depolarizing voltage steps ranging from Ϫ120 to ϩ20 mV (increment, 10 mV). Initial current amplitudes after the second command voltage pulse were plotted against the corresponding voltage. E rev was estimated by approximating the intersection with the voltage axis with a third-order polynomial function.
Statistics and Data Analysis
All results are depicted as arithmetic meanϮSEM; a 2-tailed unpaired Student t test followed by a Welch correction to account for unequal variances was used for statistical analysis. Multiple comparisons were performed using 1-way ANOVA; differences were judged significant at a PϽ0.05 significance level. Limitations include small sample size and data from a single family. All current traces were leak-subtracted off-line. Data were tested for normality (Kolmogorov-Smirnov test). Time constants were obtained by fitting a single exponential function to individual current traces that reached steady state. Voltage dependence of activation was calculated using a simplified Goldman-Hodgkin-Katz current equation.
Results
Genetic Screening
In the course of our mutation screening program, 416 patients with cardiac arrhythmias were screened for arrhythmiarelated gene mutations by analyzing exon sequences of HCN4, KCNQ1, KCNH2, SCN5A, ANK2, KCNE1, and KCNE2 genes by SSCP gel and subsequent DNA sequence analysis. 21 Among others, the novel HCN4-695X mutation was identified ( Figure 2 ). Of note, no HCN4 mutation was detected among 526 healthy individuals. 
Presentation of Patients Carrying the HCN4-695X Mutation
The index patient (III-6, 45 years, Figure 1A ) was admitted to our clinic because of a marked sinus bradycardia and recurrent ventricular premature beats (VPB) noticed during routine medical examination. Apart from sporadic symptoms of slight dizziness and episodes of palpitations, she reported no discomfort. The resting ECG showed a sinus bradycardia (41 bpm; Figure 3A ); QTc intervals were within normal range (Table 1) . Holter recording revealed sinus rhythm without pauses Ͼ2 seconds and heart rates ranging from 34 bpm at night to 147 bpm during exercise. Numerous VPB and episodes of distinctive sinus arrhythmia were apparent and could be related to the onset of physical activity. Regular left ventricular function (ejection fraction 61%) was confirmed by echocardiography and MRI. Treadmill test up to 200 W showed a regular chronotropic competence. 24, 25 The patient exhibited numerous VPB and ventricular bigeminy throughout heart rate acceleration, followed by stabilization of heart rhythm at maximum rate levels. During dobutamine-stress MRI, normal heart rate response was documented. Contrac-tility increased globally without signs of an ischemic heart disease.
Pedigree analysis ( Figure 1A ) revealed 7 additional family members carrying the HCN4-695X mutation ( Figure 1B ). All were aware of remarkably slow heart rates since childhood. Patient III.2 displayed multiple atrial premature beats (APB) and episodes of severe sinus arrhythmia during exercise ( Figure 3B and 3C) and under dobutamine stress. Notably, increasing heart rate several times fell off from 80 to 100 bpm to 40 to 60 bpm before rising again, causing nausea and chest discomfort. Syncopy suggestive of rhythmogenic events was absent from all mutant carriers except patient III.4, who had a history of recurrent and severe events with consecutive forehead injury. Because of documented episodes of sinus bradycardia up to 27 bpm, pacemaker implantation was recommended, but the patient refused. Clinical circumstances of syncope provided additional hints toward seizures (ie, prodromi, enuresis, stiffness followed by clonic jerking) and neurological examination confirmed generalized grand mal epilepsy. Treatment with antiepileptic drugs valproat and levetiracetam suppressed further events demonstrating neu- Area between blue dashed lines shows the predicted maximum work performance ϮSD, area between black dashed lines illustrates predicted maximum heart rate ϮSD, both with respect to age (29 years) and sex. 22, 23 Work load (200 W) and maximum heart rate (172 bpm) were within normal range (172 to 191 bpm), demonstrating regular chronotropic response. E and F, Multiple VPB and an episode of ventricular bigeminy were observed during heart rate acceleration (E), followed by regular sinus rhythm (F).
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Main Clinical Findings
Common to all mutant carriers is a marked sinus bradycardia with no signs of chronotropic incompetence ( Figure 3A and 3B). An increased susceptibility to premature beats (APB, VPB) and episodes of distinctive sinus arrhythmia were apparent in 5, respectively, 4 of 7 mutant carriers, and linked to the onset of adrenergic stress ( Figure 3C Figure 4 ) displayed a broad, cometshaped pattern caused by high beat-to-beat dispersion typi-cally observed in patients with sinus bradycardia. 20 Clinical evaluation did not show ischemic or structural heart disease in any family member. The rather mild clinical symptoms including sporadic dizziness and palpitations but lacking cardiac syncope or presyncope allowed for management without pacemaker implantation (for clinical data, see Table 1 ).
Clinical Classification of Family Members
Family members were classified as clinically affected when resting heart rates were Ͻ60 bpm and minimum heart rates were Ͻ40 bpm. Patients III.2 and II.3 did not fully meet the criteria as minimum heart rates exceeded 40 bpm, but genetic testing identified them as mutant carriers. Hence, they were classified as phenotypically nondistinctive ( 80 358 n/a n/a n/a n/a n/a n/a n/a 
Functional Characterization of Homomeric HCN4 and HCN4-695X Channels
Hyperpolarization-activated currents of HCN4 mutant and wild-type-channels were analyzed in transiently transfected HEK 293 cells ( Figure 5A ). 23, 26 The voltage for half maximal activation (V h ) of mutant HCN4 695X channels (Ϫ80.1Ϯ2.7 mV; nϭ14) appeared more positive than V h of wild-type HCN4 channels (Ϫ87.5Ϯ3.3 mV; nϭ15), although the difference did not reach statistical significance (Pϭ0.09), whereas the slopes of the activation curves (V c ) apparently were different (see Table 2 ; Figure 5B ,C). In the presence of intracellular cAMP (10 mol/L), V h of HCN4 channels was shifted to more positive potentials by Ϸ15 mV (Ϫ73.2Ϯ1.8 mV; nϭ16; PϽ0.01; Figure 5B ). Mutant channels, however, lacked a positive shift in the activation curve (V h ϭϪ83.1Ϯ2.4 mV; nϭ15), indicating cAMP insensitivity ( Figure 5C ). The time constant of activation () was highly voltage-dependent and similar in wild-type and mutant channels ( Figure 5D and 5E). Control recordings performed from a population of cells with a cAMP-free pipette and then repeated for another population of cells using a cAMP-containing pipette revealed that 10 mol/L cAMP to the pipette solution substantially accelerates activation of HCN4 channels (from Ϫ120 mV ϭ 1.66Ϯ0.10 seconds; nϭ13 to Ϫ120 mV cAMP ϭ0.88Ϯ0.07 seconds; nϭ12; PϽ0.01; Figure 5D ) but failed to accelerate mutant channels (from Ϫ120 mV ϭ1.19Ϯ0.16 seconds; nϭ14 to Ϫ120 mV cAMP ϭ1.37Ϯ0.10 seconds; nϭ15; Pϭ0.35; Figure 5E ). Thus, because of their cAMP insensitivity, mutant channels activate slower and at more negative potentials in the presence of cAMP than HCN4 channels. In the absence of cAMP, however, mutant channels activate at more positive potentials than wild-type channels and activate faster at Ϫ120 mV ( Table 2 ). Channel deactivation properties were derived from a 2-pulse protocol. The initial instantaneous current after the second activation step (I INS ) reflects incomplete deactivation that vanished with prolonged interpulse periods ( Figure 6A ). 23 The time-dependent decrease of this current (⌬I INS , normalized to I SS ) showed no significant difference between HCN4 and HCN4-695X channels ( Table 2 ; Figure  6B ,C). In the presence of cAMP, however, ⌬I INS of HCN4 channels increased from 47Ϯ7% (nϭ10) to 65Ϯ4% (nϭ11; Pϭ0.04) at 1-second interpulse intervals, and similar differences appeared at other interpulse intervals ( Figure 6B ). HCN4-695X channels, in contrast, showed no cAMPmediated effect on deactivation ( Table 2 and Figure 6C ). Thus, in the presence of cAMP, wild-type HCN4 channels stay longer in the open state than mutant channels. Therefore, it is conceivable that more HCN4 channels are activated during the plateau phase of action potentials, leading to a faster repolarization and an increased heart rate. Mutant channels, however, lacked this modulation. Despite these kinetic alterations, the reversal potential of mutant and wild-type channels were equivalent ( Table 2 and Figure 6D and 6E).
Heteromeric Channels Composed of HCN4 and HCN4-695X Subunits
To mimic the heterozygous cellular phenotype of patients carrying the HCN4 mutation, HEK293 cells were cotransfected using identical amounts of plasmid DNA encoding HCN4 and HCN4-695X subunits. Under basal conditions, cells expressing heteromeric channels showed a half-maximal potential of activation (V h ) of Ϫ89.6Ϯ3.3 mV (nϭ12), similar to the value determined for HCN4 channels (Ϫ87.5Ϯ3.3 mV; nϭ15; Figure 7 ) but significantly more negative than homomeric mutant channels (Ϫ80.1Ϯ2.7 mV; nϭ14; Pϭ0.01). Voltage sensitivity (ie, V c ϭϪ12.2Ϯ1.3 mV) and time constant of activation (1.47Ϯ0.13 seconds) in heteromeric channels were intermediate between wild-type and homomeric mutant channels with nonsignificant differences (see Table 2 and Figure 7) . Plots of the index patient III.6 display a comet-shaped pattern resulting from an increase in beat-to-beat dispersion usually observed at slower heart rates. 20 Note the considerable length of the plots indicating full ability to increase heart rate to a normal maximum. Arrow indicates a characteristic cluster of points outside the central comet shape caused by marked increase of N-N duration during episodes of sinus arrhythmia and compensatory pauses after premature beats. At night, maximum N-N intervals clearly exceeded 1500 ms. B, Plots of the healthy family member II.1 demonstrate a lower N-N interval dispersion, characteristic for higher heart rates leading to a more elliptic-shaped configuration. Likewise, the overall N-N interval range is smaller than in the mutant carrier still reflecting normal configuration.
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Peak currents were similar in amplitudes, ranging from Ϫ1000 to Ϫ5000 pA. Thus, heteromeric channels showed normal functional behavior under basal conditions. However, in the presence of cAMP they lacked a shift of activation voltage (basal: Ϫ89.6Ϯ3.3 mV; nϭ12, with cAMP: Ϫ85.7Ϯ3.7 mV; nϭ14; Pϭ0.42) and displayed unchanged slope of activation curves (Table 2 and Figure 7) , indicating a dominant-negative suppression of cAMP-induced HCN4 channel activation by mutant subunits.
Discussion
In mammals, cardiac pacemaker activity, controlling spontaneous excitation, originates in the SAN and is mediated by expression of the hyperpolarization-activated and nucleotidegated ion channel HCN4. 6 -8 Consistent with this, human HCN4 mutations are associated with inherited sinus node bradycardia. 9 -12 A study of a single patient expressing HCN4 mutant subunits insensitive to cAMP binding suggested that I f is crucial for chronotropic heart rate response. 9 However, a Figure 5 . Expression of HCN4 wild-type or HCN4-695X mutant subunits in HEK293 cells. A, Pulse protocol with representative whole-cell current traces on top. B, Voltage-dependent activation curves (B and C) and the potential of half-maximal activation (V h ; marked by arrowheads). In the presence of cAMP (open symbols), the activation curve of wild-type is shifted significantly by Ϸ15 mV toward more positive potentials. C, No cAMP modulation was observed in the mutant (arrowheads indicate the corresponding V h of wild-typechannels). D, In the presence of cAMP, the time constants of activation were significantly smaller in wild-type channels than in mutant channels (E). Asterisks mark significant differences. Half-maximum of activation (V h ) and slope factor (V c ), as derived from the Boltzmann function, time constant of activation at Ϫ120 mV ( act (Ϫ120 mV) ), normalized instantaneous current (⌬I INS ), reversal potential (E rev ), significantly different from wild-type (*wt), significantly different from HCN4-695X (*695X). more sophisticated model for spontaneous excitation and heart rate modulation comprising interaction of transporters and intracellular calcium release 18,27 raised fundamental concerns regarding the implication of I f in the generation, maintenance, and regulation of heart rhythm in vivo. 17 In the present study, we present a novel, cAMP-insensitive HCN4-695X mutation associated with a new clinical phenotype and address the physiological role of I f current.
Suggested Mechanisms Causing Sinus Bradycardia in HCN4-695X Mutant Carriers
Biophysical properties of homomeric HCN4-695X channels revealed insensitivity to cAMP. This deficit also was observed in the heteromeric conformation ( Figure 7 ) that most suitably reflects the heterozygous situation of our patients, indicating a dominant-negative suppression of the channel's cAMP responsiveness by the mutant subunit. In the absence of cAMP, however, heteromeric channels showed regular activation curves similar to wild-type ( Figure 7) -mirroring nonphysiological conditions. For example, DiFranceso and Mangoni 28 reported basal cytoplasmic cAMP levels of Ϸ0.2 mol/L in unstimulated SAN cells leading to a positive shift of 7 to 8 mV in the I f activation curve, whereas saturating cAMP level (100 mol/L) induced a total shift of 14.6 mV. Similarly, our experiments showed that virtually saturating levels of 10 mol/L cytoplasmic cAMP 28 caused a total shift of 14.3 mV for wild-type HCN4 channel. These observations suggest that in vivo, mimicked by heteromeric channel expression in our experiments (Figure 7) , the negative shifted I f activation curve in the resting state cannot be rescued by stimulation of basal cAMP, 28 which functionally reduces I f contribution to depolarization resulting in a decreased basal heart rate. In addition, deactivation of HCN4 channels is less efficient in the presence of cAMP, indicating that an extended open state may be advantageous for faster redepolarization and an increased heart rate. Thus, accelerated deactivation of mutant HCN4-695X channels, caused by cAMP insensitivity, favors bradycardia. In combination, both mechanisms may account for 31% reduction of basal heart rate (Ϫ21 bpm) observed in mutant carriers (Table 3) . Interestingly, in the absence of cAMP, the activation curve of homomeric mutant channels was shifted in the positive direction although compared with the wild-type difference did not reach statistical significance. This shift of voltage sensitivity, however, might be explained by an intrinsic steric inhibition of channel activity by the vacant CNBD in wildtype channels that, because of a truncated CNBD, is abolished in homomeric mutant channels 13, 29 (Figure 2 ).
Regular Autonomic Rate Control in HCN4-695X Mutant Carriers
Remarkably, and unlike the single patient expressing cAMPinsensitive HCN4-573X subunits requiring pacemaker implantation, 9 all HCN4-695X mutant carriers of our study have an intact capability to accelerate heart rate according to physiological needs and could be treated conservatively. In contrast to transgenic mice carrying the HCN4-573X mutation and showing marked reduction of resting and maximum heart rates, 16 our patients showed no significant reduction of maximum heart rates compared with unaffected relatives (Table 3) . Interestingly, in this regard, both our patients and the mutant mice 16 exhibited regular chronotropic competence during physical activity. Furthermore, we showed that heart rate variability (Kleiger SD, Table 1 ; Poincaré plot, Figure 4 ) of our mutant carriers is not compromised. However, in relation to unaffected relatives a nonsignificant increase of heart rate variability was observed compatible with a higher beat-to-beat dispersion of low basal heart rates. 20
Loss of HCN4 Activity Might Not Be Restored by Other HCN Isotypes But Is Likely to Be Substituted in Part by the "Voltage-/ Calcium-Clock" System
The absence of heart-rate-lowering effects of ivabradine in HCN4-573X mutant mice suggested that loss of cAMP sensitivity completely abolished functional I f activity that could not be restored by other HCN isotypes. 16 In another study, Cre-mediated ablation of HCN4 in adult mice induced no impairment of ␤-adrenergic heart rate acceleration even in the presence of I f blockers, demonstrating that HCN1 and HCN2 were unable to replace HCN4. 15 Furthermore, HCN2 knockout mice showed no significant alteration of heart rate regulation, neither at rest nor under adrenergic stimulation. 30 Similarly, HCN1 and HCN3 channels, which are resistant to cAMP, 31, 32 appear unable to substitute for HCN4. Thus, it seems unlikely that other HCN isotypes contribute significantly to continued heart rate modulation in HCN4-695X mutant carriers. This indicates that cardiac I f current is not critical for autonomic control of heart rate in humans. In support of this possibility, other ionic currents contribute to a "voltage-clock" that closely interacts with rhythmic ryanodine receptor-mediated intracellular calcium release ("calcium-clock"). These other currents are mediated by Land T-type Ca 2ϩ channels (I CaL , I CaT ), the delayed rectifier (I K ) and the Na ϩ /Ca 2ϩ exchanger (I NCX ). Furthermore, the contribution of these currents to pacemaker function is modulated by protein kinase A or calmodulin-dependent protein kinase II (CaMK II) phosphorylation. Recently, a coordinated system of both clocks has been suggested to drive cardiac automaticity and to largely determine autonomic chronotropy. 17, 18, 27 However, we do not exclude the possibility that cAMP-stimulated I f contributes to autonomic heart rate control, although mutant carriers in our study suggested only a minor influence.
Adrenergic Stimulation of HCN Channels May Ensure Stable Heart Rhythm
Four, respectively, 5 of 7 mutant carriers, exhibited sinus arrhythmia and premature beats (APB, VPB), including ventricular bigeminy, observed at the initial period of heart rate acceleration ( Figure 3C through 3F) . A recent study 15 reported of sinus pauses in adult transgenic mice lacking HCN4 mainly during transition from stimulated to basal cardiac states and discussed that I f might function as a depolarization reserve that ensures rhythmogenic state during conditions of changing heart rate. 15 Because of the lack of I f activation by cAMP-insensitive HCN4-695X subunits, arrhythmogenic potential of our mutant carriers might be unmasked at the onset of adrenergic stimulation. Although additional cAMP-responsive contributors ("voltage-/calciumclock" system) in particular drive the pace, current data support the idea that activated I f, at the healthy state provides a backup depolarizing force preventing arrhythmia during threshold conditions of heart rate acceleration. However, unlike the HCN4-D553N mutation associated with QT prolongation and polymorphic ventricular tachycardia, 10 our mutant carriers displayed normal QTc intervals and lacked severe ventricular arrhythmias.
Neurological Disorders of HCN4-695X Mutant Carriers
Both affected males (II.2 and III.4) showed neurological disorders. Patient II.2 was diagnosed with a schizophrenic syndrome. His son (III.4) had febrile seizures during childhood and recurrent syncope caused by generalized grand mal epilepsy. Recently, an increased susceptibility to future seizures was reported in rats 33 exhibiting slowed kinetics of the hippocampal I f resulting from recurrent febrile seizures during development. Similar mechanisms may have unmasked proepileptic changes in patient III.4, possibly caused by the mutant HCN4-695X genotype. Future studies will reveal a possible impact of HCN4 mutant channels on pathogenesis of neurological disorders with special attention to sexrelated effects because all female carriers of our study lacked neurological symptoms.
Conclusion
We describe a novel HCN4 mutation that abolishes the channel's cAMP sensitivity. Mutant carriers showed marked sinus bradycardia at rest with preserved heart rate variability and chronotropic competence. Moreover, distinctive sinus arrhythmias and premature beats emerged during chronotropic response. Because of a mild clinical phenotype without rhythmogenic syncope or high-grade ventricular arrhythmia, neither pacemaker nor implantable cardioverter-defibrillator implantation was required. We provide clinical and mechanistic evidence that cAMP-mediated modulation of I f determines basal heart rate but is not critical for ␤-adrenergic receptor-induced control of pacemaker activity. Furthermore, I f might be important to prevent arrhythmogenic state during threshold conditions of adrenergic stimulation by providing backup depolarization capacity.
CLINICAL PERSPECTIVE
Pharmacological I f inhibition is clinically used to treat patients with stable angina and sinus tachycardia. However, the role of I f in sinus node function, and particularly mechanisms underlying autonomic heart rate regulation, are incompletely understood. According to the BEAUTIFUL study, blockage of I f current in patients with stable coronary artery disease and left ventricular systolic dysfunction reduced resting heart rate by 6 bpm (8%), a minor effect related to the reduction of 21 bpm (31%) observed in HCN4-695X carriers. Our results suggest that mutant carriers might tolerate sinus bradycardia owing to their preserved ability to accelerate heart rate according to physical requirements. Thus, cardiac-specific blockage of I f may allow for significant reduction of basal heart rate without adversely affecting chronotropic competence. This suggestion has important clinical implications. Improvements in drug selectivity will reduce extracardiac side effects as well as nonspecific channel inhibition and may offer a more effective blockage of I f pacemaker currents in the future. On the other hand, as shown in the present study, functional inactivation of I f might unmask arrhythmogenic potential during adrenergic stimulation. These considerations are relevant to safety concerns other than bradycardia associated with high-dose I f -blockage.
